The main theme of the report is the analysis of global trends in research and development (R&D) in the biopharmaceutical industry by 2025.
The report examines trends in R&D funding, clinical trial activity, and the approval and launch of new drugs. It evaluates the efficiency and productivity of clinical development using an updated clinical program productivity index and identifies factors contributing to improvement. The significance of new biopharmaceutical companies and geographical shifts in clinical trial activity are also explored.